About 6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-2-[4-[(4-formyl-3-hydroxyphenyl)methyl]piperazin-1-yl]-N-prop-2-ynylpyrimidine-4-carboxamide
6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-2-[4-[(4-formyl-3-hydroxyphenyl)methyl]piperazin-1-yl]-N-prop-2-ynylpyrimidine-4-carboxamide (PubChem CID 163203722) has the molecular formula C26H28N8O3
and a molecular weight of 500.56 g/mol. Its IUPAC name is 6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-2-[4-[(4-formyl-3-hydroxyphenyl)methyl]piperazin-1-yl]-N-prop-2-ynylpyrimidine-4-carboxamide.
Molecular Properties
| Compound Name | 6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-2-[4-[(4-formyl-3-hydroxyphenyl)methyl]piperazin-1-yl]-N-prop-2-ynylpyrimidine-4-carboxamide |
| PubChem CID | 163203722 |
| Molecular Formula | C26H28N8O3 |
| Molecular Weight | 500.56 g/mol |
| Exact Mass | 500.23 |
| IUPAC Name | 6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-2-[4-[(4-formyl-3-hydroxyphenyl)methyl]piperazin-1-yl]-N-prop-2-ynylpyrimidine-4-carboxamide |
| SMILES | C#CCNC(=O)c1cc(Nc2cc(C3CC3)[nH]n2)nc(N2CCN(Cc3ccc(C=O)c(O)c3)CC2)n1 |
| InChI | InChI=1S/C26H28N8O3/c1-2-7-27-25(37)21-14-23(29-24-13-20(31-32-24)18-5-6-18)30-26(28-21)34-10-8-33(9-11-34)15-17-3-4-19(16-35)22(36)12-17/h1,3-4,12-14,16,18,36H,5-11,15H2,(H,27,37)(H2,28,29,30,31,32) |
| InChIKey | LPZMSLCWDUYQED-UHFFFAOYSA-N |
| XLogP | 2.02 |
| TPSA | 139.37 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 37 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
| MW ≤ 500 | 500.56 |
| LogP ≤ 5 | 2.02 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 9 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'aldehyde', 'substructure': 'N/A'}, {'alert_name': 'triple_bond', 'substructure': 'N/A'} |
|---|
Analyze 6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-2-[4-[(4-formyl-3-hydroxyphenyl)methyl]piperazin-1-yl]-N-prop-2-ynylpyrimidine-4-carboxamide with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-2-[4-[(4-formyl-3-hydroxyphenyl)methyl]piperazin-1-yl]-N-prop-2-ynylpyrimidine-4-carboxamide?
The IUPAC name of 6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-2-[4-[(4-formyl-3-hydroxyphenyl)methyl]piperazin-1-yl]-N-prop-2-ynylpyrimidine-4-carboxamide (CID 163203722) is 6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-2-[4-[(4-formyl-3-hydroxyphenyl)methyl]piperazin-1-yl]-N-prop-2-ynylpyrimidine-4-carboxamide.
What is the SMILES notation for 6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-2-[4-[(4-formyl-3-hydroxyphenyl)methyl]piperazin-1-yl]-N-prop-2-ynylpyrimidine-4-carboxamide?
The canonical SMILES for 6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-2-[4-[(4-formyl-3-hydroxyphenyl)methyl]piperazin-1-yl]-N-prop-2-ynylpyrimidine-4-carboxamide is C#CCNC(=O)c1cc(Nc2cc(C3CC3)[nH]n2)nc(N2CCN(Cc3ccc(C=O)c(O)c3)CC2)n1.
What is the InChIKey of 6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-2-[4-[(4-formyl-3-hydroxyphenyl)methyl]piperazin-1-yl]-N-prop-2-ynylpyrimidine-4-carboxamide?
The InChIKey is LPZMSLCWDUYQED-UHFFFAOYSA-N. The full InChI is InChI=1S/C26H28N8O3/c1-2-7-27-25(37)21-14-23(29-24-13-20(31-32-24)18-5-6-18)30-26(28-21)34-10-8-33(9-11-34)15-17-3-4-19(16-35)22(36)12-17/h1,3-4,12-14,16,18,36H,5-11,15H2,(H,27,37)(H2,28,29,30,31,32).
What are the key properties of 6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-2-[4-[(4-formyl-3-hydroxyphenyl)methyl]piperazin-1-yl]-N-prop-2-ynylpyrimidine-4-carboxamide?
6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-2-[4-[(4-formyl-3-hydroxyphenyl)methyl]piperazin-1-yl]-N-prop-2-ynylpyrimidine-4-carboxamide has a molecular weight of 500.56 g/mol, XLogP of 2.02, 9 rotatable bonds, 4 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for 6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-2-[4-[(4-formyl-3-hydroxyphenyl)methyl]piperazin-1-yl]-N-prop-2-ynylpyrimidine-4-carboxamide is sourced from PubChem (CID 163203722), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).